Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
IFPMA Code of Practice 2012

IFPMA Code of Practice 2012

Ratings: (0)|Views: 1,596 |Likes:
Published by corruptioncurrents

More info:

Published by: corruptioncurrents on Mar 01, 2012
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less





International Federationof PharmaceuticalManufacturers & Associations
IFPMACode of Practice
Advancing medical knowledge and improving global public health depend oninormation-sharing interactions by the entire medical community - rom researcherto attending physician and nurse to patient – and integrity is essential to theseexchanges. Fundamentally, there must always be confdence that prescriptiondecisions are made on an ethical and patient-ocused basis.In these interactions, it is essential that governments, the healthcare communityand patients are confdent that pharmaceutical companies, wherever they operatein the world, act in an ethical and proessional manner. Such ethical practices shouldapply not only to the promotion o medicines but more broadly to all interactionswith the healthcare community. This is the commitment that we, the InternationalFederation o Pharmaceutical Manuacturers and Associations (IFPMA) representingthe research-based pharmaceutical industry, make in our recently-revisedCode o Practice.Since its initial adoption in 1981 as the oundation o a global sel-regulatoryapproach, the Code has been regularly updated and strengthened to adaptto changing needs. The scope o the 2012 revision extends this already highstandard o pharmaceutical industry practice beyond marketing practices to coverall interactions with healthcare proessionals, medical institutions and patientorganizations.Success o the Code requires high awareness levels o both the standard itsel as wellas the established procedures or registering complaints. IFPMA member companiesare committed to inorming all their 1.3 million employees about the Code as wellas to providing thorough training. While our industry holds itsel accountable toconduct business with the highest possible ethics, we encourage others – doctors,pharmacists, nurses, academicians, patients and consumers – to become aware o this new benchmark and to ensure equally high ethical practice throughout thehealthcare sector.Focused on serving the best interests o patients, we have a moral obligationto communicate and participate in all relationships with integrity, accuracy andclarity. The IFPMA Code o Practice is a tangible example o the research-basedpharmaceutical industry’s commitment to making a strong contribution to globalpublic health while adhering to the highest standard o practice.
Eduardo Pisani
Director GeneralInternational Federation o PharmaceuticalManuacturers and Associations (IFPMA)
Table of Contents
IFPMA Guiding Principles on Ethical Conductand Promotion 
Scope and Denitions
(Article 1)
 Basis of Interactions
(Article 2)
2.1 Basis o Interactions2.2 Transparency o Promotion 5
Pre-Approval Communications andO-Label Use
(Article 3)
 Standards of Promotional Information
(Article 4)
4.1 Consistency o Product Inormation4.2 Accurate and Not Misleading4.3 Substantiation 6
Printed Promotional Material
(Article 5)
5.1 All Printed Promotional Materialincluding Advertisements5.2 Reminder Advertisements 
Electronic Materials, including Audiovisuals
(Article 6)
Interactions with Healthcare Professionals
(Article 7)
7.1 Events and Meetings7.1.1 Scientifc and Educational Objectives7.1.2 Events Involving Foreign Travel7.1.3 Promotional Inormation at Events7.1.4 Appropriate Venue7.1.5 Limits7.1.6 Entertainment7.2 Sponsorships7.3 Guests7.4 Fees or Services7.5 Gits and Other Items7.5.1 Prohibition o Cash and Personal Gits7.5.2 Promotional Aids7.5.3 Items o Medical Utility7.5.4 Guidance on ValuesPage10
(Article 8)
8.1 Samples8.2 Control and Accountability 
Clinical Research and Transparency
(Article 9)
9.1 Transparency9.2 Distinction rom Promotion 
Support for Continuing Medical Education
(Article 10)
Interactions with Patient Organizations
(Article 11)
11.1 Scope11.2 Declaration o Involvement11.3 Written Documentation11.4 Events 
Company Procedures and Responsibilities
(Article 12)
12.1 Procedures12.2 Training12.3 Responsibilities or ApprovingPromotional Communications12
Infringements, Complaints andEnforcement
(Article 13)
13.1 Complaints13.2 Measures to Ensure and EnorceCompliance13
Code of Practice Operating Procedure
(Appendix 1)
IFPMA Secretariat Standard OperatingProcedures
(Appendix 2)
Questions & Answers
IFPMA Code oPractice1

Activity (4)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->